Neurocrine Biosciences
NBIX
#1396
Rank
HK$99.72 B
Marketcap
HK$984.97
Share price
-0.07%
Change (1 day)
4.94%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): HK$15.33

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is HK$15.24. In 2022 the company made an earnings per share (EPS) of HK$12.52 an increase over its 2021 EPS that were of HK$7.39.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$15.3322.45%
2022HK$12.5269.47%
2021HK$7.39-78.21%
2020HK$33.89990%
2019HK$3.1181.82%
2018HK$1.71-113.5%
2017-HK$12.670.62%
2016-HK$12.5957.28%
2015-HK$8.0125.61%
2014-HK$6.3718.84%
2013-HK$5.36-1085.71%
2012HK$0.54-89.71%
2011HK$5.29-500%
2010-HK$1.32-86.92%
2009-HK$10.11-43.48%
2008-HK$17.88-57.8%
2007-HK$42.3792.58%
2006-HK$22.00371.67%
2005-HK$4.66-52.76%
2004-HK$9.8736.56%
2003-HK$7.23-70%
2002-HK$24.10118.31%
2001-HK$11.048.4%
2000-HK$10.1848.86%
1999-HK$6.84-20%
1998-HK$8.55-479.31%
1997HK$2.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$16.25 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.28-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$23.01-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.21 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$28.61 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.46-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$3.65-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.56-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA